Alicia Baumgartner

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 3

Top Topics

Randomized Controlled Trial

Top Venues

This page only lists publications with an associated author ORCID identifier.

Publications

Natalia Stepien, Daniel Senfter, Julia Furtner, Christine Haberler, Christian Dorfer, Thomas Czech, Daniela Lötsch-Gojo, Lisa Mayr, Cora Hedrich, Alicia Baumgartner, Maria Aliotti-Lippolis, Hannah Schned, Johannes Holler, Katharina Bruckner, Irene Slavc, Amedeo A Azizi, Andreas Peyrl, Leonhard Müllauer, Sibylle Madlener, Johannes Gojo
Proof-of-Concept for Liquid Biopsy Disease Monitoring of MYC -Amplified Group 3 Medulloblastoma by Droplet Digital PCR. Cancers 15 (9) (2023)
Natalia Stepien, Daniel Senfter, Julia Furtner, Christine Haberler, Christian Dorfer, Thomas Czech, Daniela Lötsch-Gojo, Lisa Mayr, Cora Hedrich, Alicia Baumgartner, Maria Aliotti-Lippolis, Hannah Schned, Johannes Holler, Katharina Bruckner, Irene Slavc, Amedeo A Azizi, Andreas Peyrl, Leonhard Müllauer, Sibylle Madlener, Johannes Gojo
Proof-of-Concept for Liquid Biopsy Disease Monitoring of MYC -Amplified Group 3 Medulloblastoma by Droplet Digital PCR. Cancers 15 (9) (2023)
Irene Slavc, Lisa Mayr, Natalia Stepien, Johannes Gojo, Maria Aliotti Lippolis, Amedeo A Azizi, Monika Chocholous, Alicia Baumgartner, Cora S Hedrich, Stefan Holm, Astrid Sehested, Pierre Leblond, Karin Dieckmann, Christine Haberler, Thomas Czech, Marcel Kool, Andreas Peyrl
Improved Long-Term Survival of Patients with Recurrent Medulloblastoma Treated with a "MEMMAT-like" Metronomic Antiangiogenic Approach. Cancers 14 (20) (2022)